International Primary Care Respiratory Group (IPCRG) Guidelines: Management of allergic rhinitis

Primary Care Respiratory Journal

Volumn 15, Issue 1, 2006, Pages 58-70

  Price, David ^a   Bond, Christine ^a   Bouchard, Jacques ^b   Costa, Rui ^c   Keenan, Joseph ^d   Levy, Mark L ^e   Orru, Mari ^f   Ryan, Dermot ^a   Walker, Samantha ^g   Watson, Margaret ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b St Josephs Hospital   (Canada)

^c SA   (Portugal)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f Pharm D   (Italy)

^g National Respiratory Training Centre   (United Kingdom)

Author keywords

Classification; General practice; Guideline; Management; Primary care; Rhinitis; Treatment

Indexed keywords

ACRIVASTINE; ASTEMIZOLE; AZELASTINE; BECLOMETASONE; BUDESONIDE; CETIRIZINE; CHLORPHENIRAMINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLEMASTINE; DECONGESTIVE AGENT; DESLORATADINE; EBASTINE; FEXOFENADINE; FLUNISOLIDE; FLUTICASONE; GLUCOCORTICOID; HISTAMINE H1 RECEPTOR ANTAGONIST; HYDROXYZINE; KETOTIFEN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LEVOCABASTINE; LORATADINE; MEQUITAZINE; MIZOLASTINE; MOMETASONE FUROATE; OXATOMIDE; SODIUM CHLORIDE; TERFENADINE; TRIAMCINOLONE; UNINDEXED DRUG;

AGITATION; ALLERGIC RHINITIS; ALTERNATIVE MEDICINE; ASTHMA; ATROPHY; BITTER TASTE; CARDIOTOXICITY; DISEASE CLASSIFICATION; FOLLOW UP; GLAUCOMA; HEADACHE; HEART PALPITATION; HUMAN; HYPERTENSION; IMMUNOTHERAPY; INSOMNIA; MEDICAL SOCIETY; MUCOSAL DRYNESS; PATHOPHYSIOLOGY; PATIENT CARE; PRACTICE GUIDELINE; PREGNANCY; PRIMARY MEDICAL CARE; RESTLESSNESS; REVIEW; SEDATION; SIDE EFFECT; SYSTEMIC DISEASE; THYROTOXICOSIS; TREMOR; URINE RETENTION;

EID: 31544480665     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.1016/j.pcrj.2005.11.002     Document Type: Article

References (66)

1. International Primary Care Airways Group (IPAG). Chronic airways diseases: a guide for primary care physicians. Available at the URL http://www.ipagguide.org/IPAG_copyright_draft.pdf.
2. M.L. Levy, M. Actcher, D.B. Price, T. Hausen, R.J. Halbert, and B.P. Yawn International Primary Care Respiratory Group (IPCRG) Guidelines: Diagnosis of respiratory diseases in primary care Prim Care Resp J 15 1 2006 20 34
3. D. Bellamy, J. Bouchard, S. Henrichsen, G. Johansson, A. Langhammer, J. Reid, C. van Weel, and S. Buist International Primary Care Respiratory Group (IPCRG) Guidelines: Management of chronic obstructive pulmonary disease (COPD) Prim Care Resp J 15 1 2006 48 58
4. T. van der Molen, A. Østrem, B. Stallberg, M. Stubbe Østergaard, and R.B. Singh International Primary Care Respiratory Group (IPCRG) Guidelines: Management of asthma Prim Care Resp J 15 1 2006 35 47
5. Royal College of General Practitioners. The development and implementation of clinical guidelines. Report of the clinical guidelines working group. London, 1995. RCGP.
6. C.H. Blackley Experimental researches on the causes and nature of Catarrhus Aestivus (Hay-fever or Hay-asthma) 1873 Balliere, Tindall & Cox London
7. Asthma in adults and schoolchildren. The General Practioner in Asthma Group, the British Association of Accident and Emergency Medicine, the British Paediatric Respiratory Society and the Royal College of Paediatrics and Child Health. Thorax 1997;52(Suppl 1):S2-8, S11-5, S20-1.
8. British guideline on the management of asthma. (2003) Thorax, 58 Suppl 1, Pages 1-94. BTS/SIGN. Available at URL http://www.sign.ac.uk/guidelines/ fulltext/63/index.html.
9. Global Strategy for Asthma Management and Prevention. NIH Publication No 02-3659 Issued January, 1995 (updated 2002) Management Segment (Chapter 7): Updated 2005 from the 2004 document. The GINA reports are available at URL http://www.ginasthma.org.
10. J. Bousquet, P.B. Van Cauwenberge, and N. Khaltaev Allergic Rhinitis and its Impact on Asthma (ARIA) in collaboration with the World Health Organization (WHO) J. Allergy Clin. Immunol 108 2001 S147 S336 See also Pocket Guide at URL http://www.whiar.com
11. B. Leynaert, J. Bousquet, and C. Neukirch Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects: Results from the European Community Respiratory Health Survey J Allergy Clin Immunol 104 1999 301 304
12. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC Lancet 351 1998 1225 1232
13. M. Gaga, P. Lambrou, and N. Papageorgious Eosinophils are a feature of upper and lower airway pathology in non-atopic asthma, irrespective of the presence of rhinitis Clin Exp Allergy 20 2000 663 669
14. J. Corren, A.D. Adinoff, and C.G. Irvin Changes in bronchial responsiveness following nasal provocation with allergen J Allergy Clin Immunol 89 1992 611 618
15. G.-J. Braunstahl, A. Kleinjan, and S.E. Overbeek Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients Am J Respir Crit Care Med 161 2000 2051 2057
16. M. Thomas, V.S. Kocevar, Q. Zhang, D.D. Yin, and D. Price Asthma-related health care resource use among asthmatic children with and without concomitant allergic rhinitis Pediatrics 115 2005 129 134
17. D. Price, Q. Zhang, V.S. Kocevar, D.D. Yin, and M. Thomas Effect of a concomitant diagnosis of allergic rhinitis on asthma-related health care use by adults Clin Exp Allergy 35 2005 282 287
18. A. Sheikh, and B. Hurwitz House dust mite avoidance measures for perennial allergic rhinitis. [Review] [16 refs] Cochrane Database of Systematic Reviews 4 2001 CD001563
19. L. Bemt, L. van Knapen, M.P. de Vries, M. Jansen, S. Cloosterman, and C.P. van Schayck Clinical effectivenss of a mite-allergen impermeable bed covering system in asthmatic mite-sensitive patients J Allergy Clin Immunol 114 4 2004 858 862
20. R. Leurs, M.K. Church, and M. Taglialatela H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects. [Review] [103 refs] Clin Exp Allergy 32 2002 489 498
21. P. Howarth Antihistamines in rhinoconjunctivitis. [Review] [225 refs] Clin Allergy Immunol 17 2002 179 220
22. G. Passalacqua, G.W. Canonica, and J. Bousquet Structure and classification of H1-antihistamines and overview of their activities. [Review] [320 refs] Clin Allergy Immunol 17 2002 65 100
23. L.P. Nielsen, N. Mygind, and R. Dahl Intranasal corticosteroids for allergic rhinitis: superior relief? [Review] [200 refs] Drugs 61 11 2001 1563 1579
24. H. Milgrom, B. Bender, and F. Wamboldt Of injuries and antihistamines and dosing.[comment] Ann Allergy Asthma Immunol 89 3 2002 221 223
25. F.E. Simons H1-antihistamines in children. [Review] [120 refs] Clin Allergy Immunol 17 2002 437 464
26. M. Friedlaender Overview of ocular allergy treatment. [Review] [22 refs] Curr Allergy Asthma Reports 1 4 2001 375 379
27. S. Noble, D. McTavish, and Levocabastine An update of its pharmacology, clincial efficacy an tolerability in the topical treatment of allergic rhinitis and conjunctivitis Drugs 50 6 1995 1032 1049
28. J.M. Weiner, M.J. Abramson, and R.M. Puy Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials BMJ 317 7173 1998 1624 1629
29. W.J. Fokkens, T. Godthelp, A.F. Holm, and A. Klein-Jan Local corticosteroid treatment: the effect on cells and cytokines in nasal allergic inflammation. [Review] [57 refs] Am J Rhinol 12 1 1998 21 26
30. I.M. Adcock, and G. Caramori Cross-talk between pro-inflammatory transcription factors and glucocorticoids. [Review] [52 refs] Immunol Cell Biol 79 4 2001 376 384
31. R.N. Brogden, and D. McTavish Budesonide. An updated review of its pharmacological properties, and therapeutic efficacy in asthma and rhinitis Drugs 44 3 1992 375 407
32. P.H. Ratner, B.R. Paull, S.R. Findlay, F. Hampel Jr., B. Martin, and K.M. Kral Fluticasone propionate given once daily is as effective for seasonal allergic rhinitis as beclomethasone dipropionate given twice daily J Allergy Clin Immunol 90 3:Pt 1 1992 285 291
33. D. Graft, D. Aaronson, P. Chervinsky, H. Kaiser, J. Melamed, and A. Pedinoff A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray J Allergy Clin Immunol 98 1996 724 731
34. T.J. Craig, S. Teets, E.B. Lehman, V.M. Chinchilli, and C. Zwillich Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids J Allergy Clin Immunol 101 1998 633 637
35. J. Bousquet, I. Chanal, M.C. Alquie, D. Charpin, A. Didier, and J. Germouty Prevention of pollen rhinitis symptoms: comparison of fluticasone propionate aqueous nasal spray and disodium cromoglycate aqueous nasal spray. A multicenter, double-blind, double-dummy, parallel-group study Allergy 48 1993 327 333
36. S.M. Kaszuba, F.M. Baroody, M. deTineo, L. Haney, C. Blair, and R.M. Naclerio Superiority of an intranasal corticosteroid compared with an oral antihistamine in the as-needed treatment of seasonal allergic rhinitis Arch Inter Med 161 2001 2581 2587
37. E.O. Meltzer, H.A. Orgel, E.A. Bronsky, C.T. Furukawa, J. Grossman, and C.F. LaForce A dose-ranging study of fluticasone propionate aqueous nasal spray for seasonal allergic rhinitis assessed by symptoms, rhinomanometry, and nasal cytology J Allergy Clin Immunol 86 1990 221 230
38. A.F. Holm, W.J. Fokkens, T. Godthelp, P.G. Mulder, T.M. Vroom, and E. Rijntjes A 1-year placebo-controlled study of intranasal fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis: a safety and biopsy study Clin Otolaryngol Allied Scienc 23 1998 69 73
39. F. Laliberte, M.F. Laliberte, S. Lecart, J. Bousquet, J.M. Klossec, and N. Mounedji Clinical and pathologic methods to assess the long-term safety of nasal corticosteroids. French Triamcinolone Acetonide Study Group Allergy 55 2000 718 722
40. E. Minshall, O. Ghaffar, L. Cameron, F. O'Brien, H. Quinn, and J. Rowe-Jones Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis Otolaryngol Head Neck Surg 118 1998 648 654
41. D.P. Skoner, G.S. Rachelefsky, E.O. Meltzer, P. Chervinsky, R.M. Morris, and J.M. Seltzer Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate Pediatrics 105 2000 E23
42. E.J. Schenkel, D.P. Skoner, E.A. Bronsky, S.D. Miller, D.S. Pearlman, and A. Rooklin Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray Pediatrics 105 2000 E22
43. P. Graf Rhinitis medicamentosa: aspects of pathophysiology and treatment Allergy 52 40:Suppl 1997 Suppl-34
44. P. Graf, J. Enerdal, and H. Hallen Ten days' use of oxymetazoline nasal spray with or without benzalkonium chloride in patients with vasomotor rhinitis Arch Otolaryngol Head Neck Surg 125 1999 1128 1132
45. G.P. Philip, A.S. Nayak, and W.E. Berger The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis Curr Med Res Opin 20 2004 1549 1558
46. E.O. Meltzer, K. Malmstrom, S. Lu, B.M. Prenner, L.X. Wei, and S.F. Weinstein Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial J Allergy Clin Immunol 105 2000 917 922
47. G. Ciprandi, M.A. Tosca, M. Milanese, G. Schenone, and V. Ricca Antihistamines added to an antileukotriene in treating seasonal allergic rhinitis: histamine and leukotriene antagonism Allergy Immunol 36 2004 67 70
48. M. Kurowski, P. Kuna, and P. Gorski Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation Allergy 59 2004 280 288
49. M. Abramson, R. Puy, and J. Weiner Immunotherapy in asthma: an updated systematic review. [Review] [205 refs] Allergy 54 1999 1022 1041
50. S.R. Durham, S.M. Walker, E.M. Varga, M.R. Jacobson, F. O'Brien, and W. Noble Long-term clinical efficacy of grass-pollen immunotherapy New Engl J Med 341 1999 468 475
51. R.V. Di, F. Marcucci, P. Puccinelli, S. Parmiani, F. Frati, and L. Sensi Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study Clin Exp Allergy 33 2003 206 210
52. R.A. Des, L. Paradis, J.L. Menardo, S. Bouges, J.P. Daures, and J. Bousquet Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children J Allergy Clin Immunol 99 1997 450 453
53. C. Moller, S. Dreborg, H.A. Ferdousi, S. Halken, A. Host, and L. Jacobsen Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study) J Allergy Clin Immunol 109 2002 251 256
54. K. Linde, and K.A. Jobst Homeopathy for chronic asthma Cochrane Database of Systematic Reviews 2 2000 CD000353
55. A.A. Izzo, and E. Ernst Interactions between herbal medicines and prescribed drugs: a systematic review Drugs 61 2001 2163 2175
56. P. Chanez, A.M. Vignola, P. Vic, F. Guddo, G. Bonsignore, and P. Godard Comparison between nasal and bronchial inflammation in asthmatic and control subjects Am J Respir Critic Care Med 159 1999 588 595
57. J. Bousquet, P. Van Cauwenberge, C. Bachert European Academy of Allergy and Clinical Immunology (EAACI); Allergic Rhinitis and its Impact on Asthma (ARIA) Requirements for medications commonly used in the treatment of allergic rhinitis. European Academy of Allergy and Clinical Immunology (EAACI), Allergic Rhinitis and its Impact on Asthma (ARIA) Allergy 58 2003 192 197
58. J.M. Weiner, M.J. Abramson, and R.M. Puy Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials.[comment] BMJ 317 1998 1624 1629
59. B.Q. Lanier, M.B. Abelson, and W.E. Berger Comparison of the efficacy of combined fluticasone propionate and olopatadine versus combined fluticasone propionate and fexofenadine for the treatment of allergic rhinoconjunctivitis induced by conjunctival allergen challenge Clin Ther 24 2002 1161 1174
60. D.L. Spangler, M.B. Abelson, A. Ober, and P.J. Gotnes Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models Clin Ther 25 2003 2245 2267
61. B. Leynaert, J. Bousquet, and C. Neukirch Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects: Results from the European Community Respiratory Health Survey J Allergy Clin Immunol 104 1999 301 304
62. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC Lancet 351 1998 1225 1232
63. A.L. Wright, C.J. Holberg, F.D. Martinez, M. Halonen, W. Morgan, and L.M. Taussig Epidemiology of physician-diagnosed allergic rhinitis in childhood Pediatrics 94 1994 901
64. D. Price, Q. Zhang, V.S. Kocevar, D.D. Yin, and M. Thomas Effect of a concomitant diagnosis of allergic rhinitis on asthma-related health care use by adults Clin Exp Allergy 35 2005 282 287
65. M. Thomas, V.S. Kocevar, Q. Zhang, D.D. Yin, and D. Price Asthma-related health care resource use among asthmatic children with and without concomitant allergic rhinitis Pediatrics 115 2005 129 134
66. J. Bousquet, P. van Cauwenberge, and N. Khaltaev ARIA in the pharmacy: management of allergic rhinitis symptoms in the pharmacy. Allergic rhinitis and its impact on asthma Allergy 59 2004 373 387